Markets By TradingView
5432
0

09.07.2020 Novavax Daily Analysis

NVAX was in the news this week as it received $1.6 billion from Operation Warp Speed to complete late-stage clinical development, establish large-scale

Yazar: editor_1

Yayınlanma: 9 Temmuz 2020 21:07

Güncellenme: 6 Kasım 2024 06:32

09.07.2020 Novavax Daily Analysis

NVAX was in the news this week as it received $1.6 billion from Operation Warp Speed to complete late-stage clinical development, establish large-scale manufacturing, and deliver 100 million doses of NVX‑CoV2373, Novavax’ COVID-19 vaccine candidate, as early as late 2020. It’s the largest contribution from Operation Warp Speed thus far, and many consider NVAX to be one of the leaders. The company’s vaccine aims to increase the body’s production of antibodies to block the protein that the coronavirus uses to invade cells. NVAX is expected to report the results of its phase 2 trial later this month and begin a final-stage study with 30,000 participants this fall.
En Popüler Haberler

Yorum Yap

Yazılan yorumlar hiçbir şekilde Son Ekonomi Haberleri - Türkiye Dünya - ieconomy.io görüş ve düşüncelerini yansıtmamaktadır. Yorumlar, yazan kişiyi bağlayıcı niteliktedir.

Yorumlar

Henüz yorum yapan yok! İlk yorumu siz yapın...

Borsa, Kripto, Hisse, Emtia ve Döviz Haberleri

ieconomy: Türkiye'nin en kapsamlı ekonomi haber sitesi. Son dakika haberleri ve en güncel haberler ieconomy'da.